Valion Bio, Inc. (VBIO) stock
VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.53+0.02 (+4.05%)
Close on Nov 13, 2026Market cap $2.20MP/E –Yield –
Valion Bio cash
Cash and short-term investments held at the end of each period.
Valion Bio's cash was $2.11M at Jun 30, 2026. For fiscal 2025 it was $12.65M, up 531.6% from the year before. The highest annual figure on record is $12.98M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.65M | +531.6% |
| FY2024 | Dec 31, 2024 | $2.00M | -41.0% |
| FY2023 | Dec 31, 2023 | $3.40M | -3.5% |
| FY2022 | Dec 31, 2022 | $3.52M | -72.9% |
| FY2021 | Dec 31, 2021 | $12.98M | +1142.8% |
| FY2020 | Dec 31, 2020 | $1.04M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.11M | +78.0% |
| Q1 FY2026 | Mar 31, 2026 | $7.22M | +978.5% |
| Q4 FY2025 | Dec 31, 2025 | $12.65M | +531.6% |
| Q3 FY2025 | Sep 30, 2025 | $3.45M | +57.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.18M | -67.9% |
| Q1 FY2025 | Mar 31, 2025 | $669.00K | -59.9% |
| Q4 FY2024 | Dec 31, 2024 | $2.00M | -41.0% |
| Q3 FY2024 | Sep 30, 2024 | $2.19M | -57.7% |
| Q2 FY2024 | Jun 30, 2024 | $3.69M | +38.9% |
| Q1 FY2024 | Mar 31, 2024 | $1.67M | -67.7% |
| Q4 FY2023 | Dec 31, 2023 | $3.40M | -3.5% |
| Q3 FY2023 | Sep 30, 2023 | $5.17M | -18.3% |
| Q2 FY2023 | Jun 30, 2023 | $2.66M | -70.6% |
| Q1 FY2023 | Mar 31, 2023 | $5.17M | -52.2% |
| Q4 FY2022 | Dec 31, 2022 | $3.52M | -72.9% |
| Q3 FY2022 | Sep 30, 2022 | $6.33M | +646.2% |
| Q2 FY2022 | Jun 30, 2022 | $9.05M | +457.5% |
| Q1 FY2022 | Mar 31, 2022 | $10.80M | +1700.2% |
| Q4 FY2021 | Dec 31, 2021 | $12.98M | +1142.8% |
| Q3 FY2021 | Sep 30, 2021 | $848.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $1.62M | – |
| Q1 FY2021 | Mar 31, 2021 | $600.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $1.04M | – |
See a number that looks wrong?